Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
34
KSS Quote, Financials, Valuation and Earnings
Last price:
$9.63
Seasonality move
:
0.27%
Day range:
$9.19 - $9.49
52-week range:
$6.04 - $23.02
Dividend yield:
13.31%
P/E ratio:
8.61x
P/S ratio:
0.07x
P/B ratio:
0.28x
Volume:
4.1M
Avg. volume:
7.7M
1-year change:
-58.08%
Market cap:
$1.1B
Revenue:
$16.2B
EPS (TTM):
$1.09
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Revenue | $16B | $19.4B | $18.1B | $17.5B | $16.2B | |
| Revenue Growth (YoY) | -20.12% | 21.8% | -6.87% | -3.44% | -7.18% | |
| Cost of Revenues | $10.4B | $11.4B | $11.5B | $10.5B | $9.7B | |
| Gross Profit | $5.6B | $8B | $6.6B | $7B | $6.6B | |
| Gross Profit Margin | 35.07% | 41.15% | 36.7% | 39.93% | 40.44% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $5B | $5.5B | $5.6B | $5.5B | $5.3B | |
| Other Inc / (Exp) | $38M | -$201M | -- | -- | -$76M | |
| Operating Expenses | $5.9B | $6.3B | $6.4B | $6.3B | $6.1B | |
| Operating Income | -$300M | $1.7B | $246M | $717M | $509M | |
| Net Interest Expenses | $284M | $260M | $304M | $344M | $319M | |
| EBT. Incl. Unusual Items | -$546M | $1.2B | -$58M | $373M | $114M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$383M | $281M | -$39M | $56M | $5M | |
| Net Income to Company | -$163M | $938M | -$19M | $317M | $109M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$163M | $938M | -$19M | $317M | $109M | |
| Basic EPS (Cont. Ops) | -$1.06 | $6.41 | -$0.15 | $2.88 | $0.98 | |
| Diluted EPS (Cont. Ops) | -$1.06 | $6.32 | -$0.15 | $2.85 | $0.98 | |
| Weighted Average Basic Share | $154M | $146M | $120M | $110M | $111M | |
| Weighted Average Diluted Share | $154M | $148M | $120M | $111M | $112M | |
| EBITDA | $612M | $2.3B | $1.1B | $1.5B | $1.2B | |
| EBIT | -$262M | $1.5B | $246M | $717M | $433M | |
| Revenue (Reported) | $16B | $19.4B | $18.1B | $17.5B | $16.2B | |
| Operating Income (Reported) | -$300M | $1.7B | $246M | $717M | $509M | |
| Operating Income (Adjusted) | -$262M | $1.5B | $246M | $717M | $433M | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Revenue | $3.9B | $3.7B | $3.6B | $3.4B | $3.2B | |
| Revenue Growth (YoY) | 60.09% | -4.43% | -3.88% | -5.29% | -4.41% | |
| Cost of Revenues | $2.2B | $2.1B | $2B | $1.9B | $1.8B | |
| Gross Profit | $1.7B | $1.6B | $1.5B | $1.5B | $1.4B | |
| Gross Profit Margin | 42.55% | 42.4% | 42.68% | 43.14% | 43.27% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.2B | $1.3B | $1.2B | $1.2B | $1.2B | |
| Other Inc / (Exp) | -$201M | -- | -- | -- | -- | |
| Operating Expenses | $1.4B | $1.5B | $1.4B | $1.4B | $1.3B | |
| Operating Income | $273M | $82M | $98M | $43M | $60M | |
| Net Interest Expenses | $67M | $68M | $84M | $83M | $76M | |
| EBT. Incl. Unusual Items | $5M | $14M | $14M | -$40M | -$16M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$9M | -- | -- | -$13M | -$1M | |
| Net Income to Company | $14M | $14M | $14M | -$27M | -$15M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $14M | $14M | $14M | -$27M | -$15M | |
| Basic EPS (Cont. Ops) | $0.09 | $0.11 | $0.13 | -$0.24 | -$0.13 | |
| Diluted EPS (Cont. Ops) | $0.09 | $0.11 | $0.13 | -$0.24 | -$0.13 | |
| Weighted Average Basic Share | $154M | $127M | $110M | $111M | $111M | |
| Weighted Average Diluted Share | $156M | $129M | $111M | $111M | $111M | |
| EBITDA | $283M | $282M | $286M | $231M | $235M | |
| EBIT | $72M | $82M | $98M | $43M | $60M | |
| Revenue (Reported) | $3.9B | $3.7B | $3.6B | $3.4B | $3.2B | |
| Operating Income (Reported) | $273M | $82M | $98M | $43M | $60M | |
| Operating Income (Adjusted) | $72M | $82M | $98M | $43M | $60M | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Revenue | $17.4B | $19.3B | $18B | $17.3B | $16.1B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $10.8B | $11.3B | $11.4B | $10.4B | $9.6B | |
| Gross Profit | $6.6B | $7.9B | $6.6B | $6.9B | $6.5B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $5.1B | $5.6B | $5.5B | $5.5B | $5.2B | |
| Other Inc / (Exp) | -$97M | -- | -- | -- | -- | |
| Operating Expenses | $6B | $6.4B | $6.3B | $6.3B | $6B | |
| Operating Income | $625M | $1.5B | $262M | $662M | $526M | |
| Net Interest Expenses | $293M | $261M | $320M | $343M | $312M | |
| EBT. Incl. Unusual Items | $235M | $1.2B | -$58M | $319M | $138M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$157M | $290M | -$39M | $43M | $17M | |
| Net Income to Company | $392M | $938M | -$19M | $276M | $121M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $392M | $938M | -$19M | $276M | $121M | |
| Basic EPS (Cont. Ops) | $2.55 | $6.52 | -$0.41 | $2.51 | $1.09 | |
| Diluted EPS (Cont. Ops) | $2.51 | $6.44 | -$0.43 | $2.48 | $1.09 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $1.4B | $2.3B | $1.1B | $1.4B | $1.2B | |
| EBIT | $528M | $1.5B | $262M | $662M | $450M | |
| Revenue (Reported) | $17.4B | $19.3B | $18B | $17.3B | $16.1B | |
| Operating Income (Reported) | $625M | $1.5B | $262M | $662M | $526M | |
| Operating Income (Adjusted) | $528M | $1.5B | $262M | $662M | $450M | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Revenue | $3.9B | $3.7B | $3.6B | $3.4B | $3.2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2.2B | $2.1B | $2B | $1.9B | $1.8B | |
| Gross Profit | $1.7B | $1.6B | $1.5B | $1.5B | $1.4B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.2B | $1.3B | $1.2B | $1.2B | $1.2B | |
| Other Inc / (Exp) | -$201M | -- | -- | -- | -- | |
| Operating Expenses | $1.4B | $1.5B | $1.4B | $1.4B | $1.3B | |
| Operating Income | $273M | $82M | $98M | $43M | $60M | |
| Net Interest Expenses | $67M | $68M | $84M | $83M | $76M | |
| EBT. Incl. Unusual Items | $5M | $14M | $14M | -$40M | -$16M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$9M | -- | -- | -$13M | -$1M | |
| Net Income to Company | $14M | $14M | $14M | -$27M | -$15M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $14M | $14M | $14M | -$27M | -$15M | |
| Basic EPS (Cont. Ops) | $0.09 | $0.11 | $0.13 | -$0.24 | -$0.13 | |
| Diluted EPS (Cont. Ops) | $0.09 | $0.11 | $0.13 | -$0.24 | -$0.13 | |
| Weighted Average Basic Share | $154M | $127M | $110M | $111M | $111M | |
| Weighted Average Diluted Share | $156M | $129M | $111M | $111M | $111M | |
| EBITDA | $283M | $282M | $286M | $231M | $235M | |
| EBIT | $72M | $82M | $98M | $43M | $60M | |
| Revenue (Reported) | $3.9B | $3.7B | $3.6B | $3.4B | $3.2B | |
| Operating Income (Reported) | $273M | $82M | $98M | $43M | $60M | |
| Operating Income (Adjusted) | $72M | $82M | $98M | $43M | $60M | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2.3B | $1.6B | $153M | $183M | $134M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | $2.6B | $3.1B | $3.2B | $2.9B | $2.9B | |
| Prepaid Expenses | $172M | $164M | $170M | $166M | $139M | |
| Other Current Assets | $13M | $15M | $14M | $14M | $11M | |
| Total Current Assets | $5.8B | $5B | $3.7B | $3.4B | $3.4B | |
| Property Plant And Equipment | $9.1B | $9.6B | $10.2B | $10.2B | $9.7B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $141M | $140M | $138M | $148M | $159M | |
| Total Assets | $15.3B | $15.1B | $14.3B | $14B | $13.6B | |
| Accounts Payable | $1.5B | $1.7B | $1.3B | $1.1B | $1B | |
| Accrued Expenses | $725M | $700M | $668M | $672M | $620M | |
| Current Portion Of Long-Term Debt | -- | -- | $275M | -- | $353M | |
| Current Portion Of Capital Lease Obligations | $276M | $263M | $205M | $185M | $183M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $3B | $3.3B | $3.1B | $2.6B | $3.1B | |
| Long-Term Debt | $2.5B | $1.9B | $1.6B | $1.6B | $1.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $10.1B | $10.4B | $10.6B | $10.1B | $9.8B | |
| Common Stock | $4M | $4M | $4M | $2M | $1M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $5.2B | $4.7B | $3.8B | $3.9B | $3.8B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $5.2B | $4.7B | $3.8B | $3.9B | $3.8B | |
| Total Liabilities and Equity | $15.3B | $15.1B | $14.3B | $14B | $13.6B | |
| Cash and Short Terms | $2.3B | $1.6B | $153M | $183M | $134M | |
| Total Debt | $2.5B | $1.9B | $2B | $1.7B | $1.8B | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.6B | $646M | $286M | $228M | $153M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | $2.7B | $3.7B | $3.5B | $3.1B | $3.1B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $919M | $381M | $347M | $345M | $290M | |
| Total Current Assets | $5.2B | $4.8B | $4.2B | $3.7B | $3.6B | |
| Property Plant And Equipment | $9B | $10B | $10.2B | $10.2B | $9.6B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $449M | $476M | $380M | $460M | $476M | |
| Total Assets | $14.7B | $15.3B | $14.7B | $14.3B | $13.6B | |
| Accounts Payable | $1.4B | $1.7B | $1.3B | $1.2B | $1B | |
| Accrued Expenses | $1.3B | $1.3B | $1.2B | $1.3B | $1.2B | |
| Current Portion Of Long-Term Debt | -- | $164M | $111M | -- | $353M | |
| Current Portion Of Capital Lease Obligations | $271M | $235M | $204M | $173M | $179M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $2.9B | $3.4B | $3.6B | $3B | $3.3B | |
| Long-Term Debt | $1.9B | $1.7B | $1.6B | $1.6B | $1.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $9.6B | $10.8B | $11B | $10.5B | $9.9B | |
| Common Stock | $4M | $4M | $2M | $2M | $1M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $5.1B | $4.5B | $3.7B | $3.8B | $3.8B | |
| Total Liabilities and Equity | $14.7B | $15.3B | $14.7B | $14.3B | $13.6B | |
| Cash and Short Terms | $1.6B | $646M | $286M | $228M | $153M | |
| Total Debt | $1.9B | $1.9B | $2.5B | $2B | $2.1B | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$163M | $938M | -$19M | $317M | $109M | |
| Depreciation & Amoritzation | $874M | $838M | $808M | $749M | $743M | |
| Stock-Based Compensation | $40M | $48M | $30M | $42M | $30M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | $768M | -$467M | -$116M | $315M | -$60M | |
| Cash From Operations | $1.3B | $2.3B | $282M | $1.2B | $648M | |
| Capital Expenditures | $334M | $605M | $826M | $577M | $466M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$137M | -$570M | -$783M | -$562M | -$467M | |
| Dividends Paid (Ex Special Dividend) | -$108M | -$147M | -$239M | -$220M | -$222M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $2.1B | $515M | $96M | $28M | $199M | |
| Long-Term Debt Repaid | -$1.6B | -$1.2B | -$106M | -$368M | -$192M | |
| Repurchase of Common Stock | -$30M | -$1.4B | -$679M | -$16M | -$10M | |
| Other Financing Activities | -$19M | -$203M | -$6M | -- | -$5M | |
| Cash From Financing | $347M | -$2.4B | -$933M | -$576M | -$230M | |
| Beginning Cash (CF) | $723M | $2.3B | $1.6B | $153M | $183M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.5B | -$684M | -$1.4B | $30M | -$49M | |
| Ending Cash (CF) | $2.3B | $1.6B | $153M | $183M | $134M | |
| Levered Free Cash Flow | $1B | $1.7B | -$544M | $591M | $182M | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $14M | $14M | $14M | -$27M | -$15M | |
| Depreciation & Amoritzation | $211M | $200M | $188M | $188M | $175M | |
| Stock-Based Compensation | $12M | $18M | $9M | $10M | $9M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -$75M | -$668M | -$336M | -$202M | -$191M | |
| Cash From Operations | $278M | -$460M | -$202M | -$7M | -$92M | |
| Capital Expenditures | $59M | $221M | $94M | $126M | $110M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$57M | -$217M | -$94M | -$126M | -$108M | |
| Dividends Paid (Ex Special Dividend) | -$39M | -$63M | -$55M | -$55M | -$14M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $500M | $4M | $685M | $263M | $258M | |
| Long-Term Debt Repaid | -$1.1B | -$29M | -$189M | -$21M | -$21M | |
| Repurchase of Common Stock | -$68M | -$176M | -$12M | -$9M | -$4M | |
| Other Financing Activities | -$200M | -- | -- | -- | -- | |
| Cash From Financing | -$883M | -$264M | $429M | $178M | $219M | |
| Beginning Cash (CF) | $2.3B | $1.6B | $153M | $183M | $134M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$662M | -$941M | $133M | $45M | $19M | |
| Ending Cash (CF) | $1.6B | $646M | $286M | $228M | $153M | |
| Levered Free Cash Flow | $219M | -$681M | -$296M | -$133M | -$202M | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $392M | $938M | -$19M | $276M | $121M | |
| Depreciation & Amoritzation | $858M | $827M | $796M | $749M | $730M | |
| Stock-Based Compensation | $37M | $54M | $21M | $43M | $29M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | $898M | -$1.1B | $216M | $449M | -$49M | |
| Cash From Operations | $1.6B | $1.5B | $540M | $1.4B | $563M | |
| Capital Expenditures | $231M | $767M | $699M | $609M | $450M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$32M | -$730M | -$660M | -$594M | -$449M | |
| Dividends Paid (Ex Special Dividend) | -$39M | -$171M | -$231M | -$220M | -$181M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $506M | $19M | $777M | -$394M | $194M | |
| Long-Term Debt Repaid | -$2.2B | -$121M | -$266M | -$200M | -$192M | |
| Repurchase of Common Stock | -$70M | -$1.5B | -$515M | -$13M | -$5M | |
| Other Financing Activities | -$200M | -- | -- | -- | -- | |
| Cash From Financing | -$2B | -$1.8B | -$240M | -$827M | -$189M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$430M | -$963M | -$360M | -$58M | -$75M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $1.3B | $766M | -$159M | $754M | $113M | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $14M | $14M | $14M | -$27M | -$15M | |
| Depreciation & Amoritzation | $211M | $200M | $188M | $188M | $175M | |
| Stock-Based Compensation | $12M | $18M | $9M | $10M | $9M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -$75M | -$668M | -$336M | -$202M | -$191M | |
| Cash From Operations | $278M | -$460M | -$202M | -$7M | -$92M | |
| Capital Expenditures | $59M | $221M | $94M | $126M | $110M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$57M | -$217M | -$94M | -$126M | -$108M | |
| Dividends Paid (Ex Special Dividend) | -$39M | -$63M | -$55M | -$55M | -$14M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $500M | $4M | $685M | $263M | $258M | |
| Long-Term Debt Repaid | -$1.1B | -$29M | -$189M | -$21M | -$21M | |
| Repurchase of Common Stock | -$68M | -$176M | -$12M | -$9M | -$4M | |
| Other Financing Activities | -$200M | -- | -- | -- | -- | |
| Cash From Financing | -$883M | -$264M | $429M | $178M | $219M | |
| Beginning Cash (CF) | $2.3B | $1.6B | $153M | $183M | $134M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$662M | -$941M | $133M | $45M | $19M | |
| Ending Cash (CF) | $1.6B | $646M | $286M | $228M | $153M | |
| Levered Free Cash Flow | $219M | -$681M | -$296M | -$133M | -$202M | |
Get KSS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
KSS
Sector
P/E ratio
8.61x
16.92x
PEG ratio
--
0.17x
P/B ratio
0.28x
1.42x
Price / LTM sales
0.07x
0.68x
Growth Metrics
KSS
Sector
Revenue growth
-4.41%
0.64%
Earnings growth
-74.25%
-1.02%
Revenue (5-year growth)
-4.08%
3.61%
Earnings forecast
-$0.22
$0.24
Profitability
KSS
Sector
Profitability FY 2024
$6.6B
$456.7M
Return on invested capital
2.08%
4.58%
Return on assets
0.86%
2.72%
Return on equity
3.18%
6.7%
Earnings Date
Last Earnings Date
May
29
Next Earnings Date
Aug
28
Estimated Next Earnings Date
Aug
28
Balance Sheet
KSS
Sector
Total cash
$153M
$139.6M
Short term investments
--
$46.8M
Total assets
$13.6B
$1.4B
Long term debt
$2.1B
$128.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
